Enliven Therapeutics (NASDAQ:ELVN) Stock Price Down 3 9% After Insider Selling themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) gapped up prior to trading on Tuesday . The stock had previously closed at $18.30, but opened at $18.96. Enliven Therapeutics shares last traded at $18.77, with a volume of 11,556 shares changing hands. Wall Street Analyst Weigh In Separately, Mizuho started coverage on Enliven Therapeutics in […]
Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) Director Rahul D. Ballal sold 3,237 shares of Enliven Therapeutics stock in a transaction that occurred on Monday, April 1st. The shares were sold at an average price of $19.08, for a total transaction of $61,761.96. Following the transaction, the director now directly owns 22,341 shares of […]
Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) insider Joseph P. Lyssikatos sold 12,000 shares of the firm’s stock in a transaction dated Monday, April 1st. The shares were sold at an average price of $18.60, for a total value of $223,200.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, […]
Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) Director Rahul D. Ballal sold 3,237 shares of the stock in a transaction that occurred on Monday, April 1st. The shares were sold at an average price of $19.08, for a total transaction of $61,761.96. Following the completion of the transaction, the director now owns 22,341 shares […]